CL 25 Pill - yellow oval
Pill with imprint CL 25 is Yellow, Oval and has been identified as Pantoprazole Sodium Delayed-Release 40 mg. It is supplied by Macleods Pharmaceuticals Limited.
Pantoprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; GERD; Gastritis/Duodenitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CL 25
Pantoprazole Sodium Delayed-Release
- Imprint
- CL 25
- Strength
- 40 mg
- Color
- Yellow
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Macleods Pharmaceuticals Limited
- National Drug Code (NDC)
- 33342-0020
- Inactive Ingredients
-
crospovidone,
ferric oxide yellow,
mannitol,
povidone,
propylene glycol,
sodium carbonate,
titanium dioxide,
triethyl citrate,
ferrosoferric oxide,
isopropyl alcohol,
butyl alcohol,
alcohol,
calcium stearate,
hypromellose 2910 (5 mPa.s),
shellac,
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.
Related images for "CL 25"
More about pantoprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (427)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: proton pump inhibitors
- Breastfeeding
Patient resources
- Pantoprazole drug information
- Pantoprazole (Intravenous) (Advanced Reading)
- Pantoprazole Delayed-Release Tablets
- Pantoprazole Delayed-Release Granules
- Pantoprazole Injection
Other brands
Professional resources
- Pantoprazole monograph
- Pantoprazole (FDA)
- Pantoprazole Granules (FDA)
- Pantoprazole Injection (FDA)
- Pantoprazole Oral Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
